In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a clinical study to confirm the safety of long-term administration of a therapeutic drug.
Amgen takes a lighthearted approach in latest Otezla campaign around mild-to-moderate psoriasis
Amgen is adopting a lighthearted tone in its latest Otezla campaign, highlighting psoriasis treatment and encouraging patients to “live in the moment.” The new work,
August 15, 2023